Adocia : Document AMF CP. 2023E938855

November 20, 2023 at 09:46 am EST

Date	Created	Title	Type	Company	Link
2023-11-20T00:00:00	2023-11-20T15:42:04.09	DeclarationPositionsCourtes	Document	ELIS	Link
2023-11-20T00:00:00	2023-11-20T15:42:03.32	DeclarationPositionsCourtes	Document	ELIS	Link
2023-11-20T00:00:00	2023-11-20T15:42:02.517	DeclarationPositionsCourtes	Document	CGG	Link
2023-11-20T00:00:00	2023-11-20T15:40:05.78	DeclarationPositionsCourtes	Document	UBISOFT ENTERTAINMENT	Link
2023-11-20T00:00:00	2023-11-20T15:40:04.983	DeclarationPositionsCourtes	Document	VALEO	Link
2023-11-20T00:00:00	2023-11-20T15:40:04.157	DeclarationPositionsCourtes	Document	ELIOR GROUP	Link
2023-11-20T00:00:00	2023-11-20T15:40:03.37	DeclarationPositionsCourtes	Document	REXEL	Link
2023-11-20T00:00:00	2023-11-20T15:40:02.52	DeclarationPositionsCourtes	Document	ELIS	Link
2023-11-20T00:00:00	2023-11-20T15:38:05.837	DeclarationPositionsCourtes	Document	SPIE SA	Link
2023-11-20T00:00:00	2023-11-20T15:38:05.067	DeclarationPositionsCourtes	Document	VALEO	Link
2023-11-20T00:00:00	2023-11-20T15:38:04.257	DeclarationPositionsCourtes	Document	CAPGEMINI	Link
2023-11-20T00:00:00	2023-11-20T15:38:03.37	DeclarationPositionsCourtes	Document	REXEL	Link
2023-11-20T00:00:00	2023-11-20T15:38:02.53	DeclarationPositionsCourtes	Document	ADOCIA	Link
2023-11-20T00:00:00	2023-11-20T15:32:02.51	DeclarationAchatVente	Document	ESI GROUP	Link
null	2023-11-20T14:44:02.607	NotesEtAutresInformations	Depot	TECHNICOLOR CREATIVE STUDIOS	Link
2023-11-20T00:00:00	2023-11-20T14:26:02.563	DeclarationAchatVente	Document	ESI GROUP	Link
2023-11-20T00:00:00	2023-11-20T14:20:02.58	DeclarationAchatVente	Document	ESI GROUP	Link
null	2023-11-20T12:00:02.937	Prospectus	Approbation	BPCE	Link
null	2023-11-20T11:56:10.41	Prospectus	Approbation	CREDIT AGRICOLE S.A.	Link
null	2023-11-20T11:56:07.86	Prospectus	Approbation	CREDIT AGRICOLE S.A.	Link
2023-11-20T00:00:00	2023-11-20T10:04:02.613	DeclarationAchatVente	Document	PCAS	Link
2023-11-20T00:00:00	2023-11-20T10:02:02.69	DeclarationAchatVente	Document	OBER	Link
null	2023-11-20T08:10:04.063	NotesEtAutresInformations	Conformite	COLAS SA	Link
null	2023-11-18T10:22:02.37	undefined	Communique	CAISSE FRANCAISE DE FINANCEMENT LOCAL	Link
null	2023-11-18T10:20:50.247	undefined	Communique	NATIXIS STRUCTURED ISSUANCE SA	Link
null	2023-11-18T10:20:47.407	undefined	Communique	NATIXIS STRUCTURED ISSUANCE SA	Link
null	2023-11-18T10:20:02.417	undefined	Communique	NATIXIS STRUCTURED ISSUANCE SA	Link
null	2023-11-18T10:18:43.61	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-18T10:18:40.707	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-18T10:16:59.673	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-18T10:16:56.743	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-18T10:16:53.423	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-18T10:16:50.49	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-18T10:16:47.6	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-18T10:16:02.62	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-18T10:15:18.857	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-18T10:15:15.507	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-18T10:15:12.45	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-18T10:15:09.367	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-18T10:12:02.527	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-18T10:11:18.587	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-18T10:11:15.21	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-18T10:11:11.647	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-18T10:11:08.4	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-18T10:08:02.36	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-18T10:07:06.577	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-18T10:04:02.393	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-18T10:02:04.893	undefined	Communique	ARKEMA	Link
2023-11-17T00:00:00	2023-11-17T18:06:04.993	DeclarationDirigeants	Document	AXA	Link
2023-11-17T00:00:00	2023-11-17T18:06:04.197	DeclarationDirigeants	Document	AXA	Link
2023-11-17T00:00:00	2023-11-17T18:06:03.383	DeclarationDirigeants	Document	HERMES INTERNATIONAL	Link
2023-11-17T00:00:00	2023-11-17T18:04:06.6	DeclarationDirigeants	Document	ARVERNE GROUP S.A.	Link
2023-11-17T00:00:00	2023-11-17T18:04:05.807	DeclarationDirigeants	Document	VINCI	Link
2023-11-17T00:00:00	2023-11-17T18:04:05.03	DeclarationDirigeants	Document	COVIVIO	Link
2023-11-17T00:00:00	2023-11-17T18:04:04.217	DeclarationDirigeants	Document	CYBERGUN	Link
2023-11-17T00:00:00	2023-11-17T18:04:03.393	DeclarationDirigeants	Document	BOUYGUES	Link
2023-11-17T00:00:00	2023-11-17T18:02:06.237	DeclarationDirigeants	Document	SIDETRADE	Link
2023-11-17T00:00:00	2023-11-17T18:02:05.457	DeclarationDirigeants	Document	METROPOLE TELEVISION	Link
2023-11-17T00:00:00	2023-11-17T18:02:04.46	DeclarationDirigeants	Document	STREAMWIDE	Link
2023-11-17T00:00:00	2023-11-17T18:02:03.393	DeclarationDirigeants	Document	WENDEL	Link
2023-11-17T00:00:00	2023-11-17T15:50:04.243	DeclarationPositionsCourtes	Document	EUROFINS SCIENTIFIC SE	Link
2023-11-17T00:00:00	2023-11-17T15:50:03.427	DeclarationPositionsCourtes	Document	VALEO	Link
2023-11-17T00:00:00	2023-11-17T15:48:07.063	DeclarationPositionsCourtes	Document	CGG	Link
2023-11-17T00:00:00	2023-11-17T15:48:06.213	DeclarationPositionsCourtes	Document	AIR FRANCE-KLM	Link
2023-11-17T00:00:00	2023-11-17T15:48:05.357	DeclarationPositionsCourtes	Document	VALLOUREC	Link
2023-11-17T00:00:00	2023-11-17T15:48:04.29	DeclarationPositionsCourtes	Document	WENDEL	Link
2023-11-17T00:00:00	2023-11-17T15:48:03.44	DeclarationPositionsCourtes	Document	ELIOR GROUP	Link
2023-11-17T00:00:00	2023-11-17T15:46:06.917	DeclarationPositionsCourtes	Document	ATOS SE	Link
2023-11-17T00:00:00	2023-11-17T15:46:05.15	DeclarationPositionsCourtes	Document	SOITEC	Link
2023-11-17T00:00:00	2023-11-17T15:46:04.33	DeclarationPositionsCourtes	Document	REXEL	Link
2023-11-17T00:00:00	2023-11-17T15:46:03.463	DeclarationPositionsCourtes	Document	ALSTOM	Link
2023-11-17T00:00:00	2023-11-17T15:44:08.15	DeclarationPositionsCourtes	Document	CGG	Link
2023-11-17T00:00:00	2023-11-17T15:44:07.3	DeclarationPositionsCourtes	Document	SOLUTIONS 30 SE	Link
2023-11-17T00:00:00	2023-11-17T15:44:05.71	DeclarationPositionsCourtes	Document	CELLECTIS	Link
2023-11-17T00:00:00	2023-11-17T15:42:05.573	DeclarationAchatVente	Document	ESI GROUP	Link
2023-11-17T00:00:00	2023-11-17T15:40:04.673	DeclarationAchatVente	Document	ESI GROUP	Link
2023-11-17T00:00:00	2023-11-17T14:26:03.5	ResultatOffre	Document	BALYO	Link
2023-11-17T00:00:00	2023-11-17T14:12:03.433	DeclarationAchatVente	Document	PCAS	Link
2023-11-17T00:00:00	2023-11-17T13:58:04.293	Declarations	Document	MERCIALYS	Link
2023-11-17T00:00:00	2023-11-17T13:58:03.393	DeclarationAchatVente	Document	OBER	Link
2023-11-17T00:00:00	2023-11-17T13:54:03.54	DeclarationAchatVente	Document	ESI GROUP	Link
null	2023-11-17T10:22:03.493	undefined	Communique	AGENCE FRANCE LOCALE	Link
null	2023-11-17T10:21:33.397	undefined	Communique	CAISSE FRANCAISE DE FINANCEMENT LOCAL	Link
null	2023-11-17T10:20:48.277	undefined	Communique	NATIXIS STRUCTURED ISSUANCE SA	Link
null	2023-11-17T10:20:45.65	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:20:42.303	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:20:39.5	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:19:26.247	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:19:22.43	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:19:19.47	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:19:16.27	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:19:12.397	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:15:24.517	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:15:21.483	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:15:18.14	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:15:14.947	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:12:03.807	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:11:48.96	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:08:47.727	undefined	Communique	BNP PARIBAS ISSUANCE B.V.	Link
null	2023-11-17T10:06:51.17	undefined	Communique	NATIXIS STRUCTURED ISSUANCE SA	Link

Attachments

Original Link
Original Document
Permalink

Disclaimer

Adocia SA published this content on 20 November 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 November 2023 14:45:04 UTC.

	1st Jan change	Capi.
ADOCIA	-26.95%	129M
VERTEX PHARMACEUTICALS INCORPORATED	-2.31%	103B
REGENERON PHARMACEUTICALS, INC.	+0.56%	95.28B
ARGENX SE	+1.69%	22.15B
BIONTECH SE	-17.37%	21.02B
GENMAB A/S	-9.30%	18.15B
WUXI APPTEC CO., LTD.	-41.01%	16.74B
BEIGENE, LTD.	-14.85%	16.05B
NEUROCRINE BIOSCIENCES, INC.	+3.21%	13.68B
SAREPTA THERAPEUTICS, INC.	+33.54%	12.17B

1st Jan change

Capi.

ADOCIA

-26.95%

129M

VERTEX PHARMACEUTICALS INCORPORATED

-2.31%

103B

REGENERON PHARMACEUTICALS, INC.

+0.56%

95.28B

ARGENX SE

+1.69%

22.15B

BIONTECH SE

-17.37%

21.02B

GENMAB A/S

-9.30%

18.15B

WUXI APPTEC CO., LTD.

-41.01%

16.74B

BEIGENE, LTD.

-14.85%

16.05B

NEUROCRINE BIOSCIENCES, INC.

+3.21%

13.68B

SAREPTA THERAPEUTICS, INC.

+33.54%

12.17B

Market Closed - Euronext Paris Other stock markets 11:35:06 2024-04-26 am EDT			5-day change	1st Jan Change
8.43 ^EUR	+4.46%		-0.24%	-26.95%

Apr. 24	Adocia SA Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Mar. 22	Adocia: announces fund-raising	CF

Adocia SA Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 24	CI
Adocia: announces fund-raising	Mar. 22	CF
Adocia SA announced that it expects to receive ?2 million in funding	Mar. 20	CI
Adocia Reveals Promising Preclinical Data on Adocia Islets for Cell Therapy of Diabetes	Nov. 09	CI
Adocia: positive study data for BC Combo	23-10-23	CF
Adocia SA Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-18	CI
Adocia: refinancing operations completed	23-07-26	CF
Adocia SA announced that it has received ?9.999993 million in funding from Bpifrance Investissement SAS, Vester Finance SA	23-07-19	CI
Adocia: exclusive right to negotiate M1Pram with Sanofi	23-07-06	CF
Sanofi Secures EUR10 Million Exclusivity Deal for Adocia's Diabetes Drug	23-07-06	MT
Adocia Signs an Exclusivity Agreement with Sanofi for M1Pram	23-07-05	CI
Adocia SA announced that it expects to receive â‚¬10 million in funding	23-07-04	CI
Adocia Requests Trading Halt on Euronext Paris	23-06-01	MT
Adocia: listing suspended pending a press release	23-06-01	CF
Adocia SA Auditor Raises 'Going Concern' Doubt	23-04-27	CI
Global markets live: Deliveroo, Adobe, Berkshire Hathaway, First republic Bank, Robinhood Markets...	23-03-16
Adocia SA Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-14	CI
Adocia: CDC drops below 10% stake	23-01-20	CF
Adocia Jumps 11% as BioChaperone Lispro Shows Faster Absorption in Early-stage Insulin Injection Trial	22-12-29	MT
Adocia: share price rises on positive study results	22-12-29	CF
Adocia SA Announces the Successful Phase 1 Study for Biochaperone® Lispro with Partner Tonghua Dongbao	22-12-29	CI
Adocia SA announced that it has received €5.999997 million in funding	22-10-30	CI
Adocia's Phase 2 Study of M1Pram Shows Better Weight Loss, Appetite Control in Diabetic Obese People; Shares Surge 13%	22-10-06	MT
Adocia Sa Announces Exceptional Weight Loss for Obese People with Type 1 Diabetes Using M1pram in A Post-Hoc Analysis	22-10-06	CI
Adocia SA Reports Earnings Results for the Half Year Ended June 30, 2022	22-09-19	CI

Adocia

Equities

ADOC

FR0011184241

Biotechnology & Medical Research

Adocia : Document AMF CP. 2023E938855

Latest news about Adocia

Chart Adocia

Company Profile

Income Statement Evolution

Ratings for Adocia

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Bio Therapeutic Drugs